At the upcoming 12th European Multidisciplinary Congress on Urological Cancers (EMUC20), experts from across and beyond Europe will examine the best practices and challenges in managing genitourinary (GU) malignancies. This leading congress in GU cancers for European medical specialists is set to take place from 12 to 15 November 2020 in Athens, making it the first Greek edition of EMUC.
EMUC20 is a frontline congress that will identify optimal therapies and address gaps in clinical practices in onco-urology. This congress is designed to encourage relevant discussions on innovative treatment, the limits of standard therapies, and the impact of new research outcomes. Its reputation as prime European platform for professional and scientific exchanges in GU oncology has been well-established throughout the years.
The congress brings together esteemed specialists and healthcare professionals from various disciplines, thanks to the collaborative efforts of the European Society for Medical Oncology (ESMO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Association of Urology (EAU).
Skills training for urologists, radiologists, pathologists and related healthcare professionals are always part of the EMUC Scientific Programme. Dedicated mentors, tutors and key opinion leaders will offer their expertise during the Hands-on Training sessions and specialised courses organised by the European School of Urology (ESU) at EMUC20.
Come join us and be in the forefront of medical discoveries as EMUC20 casts a critical look at controversial issues and evaluates the insights in clinical practice concerning GU cancers.
Access the EMUC20 website